SNDL Inc.
SNDL- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001766600
No open-market purchases or sales by SNDL Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Holders of 5% or more of SNDL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of SNDL Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of SNDL Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on SNDL Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 20, 202510:05 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 0.29%754.9K shares | −9.70 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20258:58 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%29.2M shares | New | Jun 30, 2025 | SEC |
| Feb 14, 2023 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
| Aug 25, 2022 | ETF Managers Group, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell SNDL Inc. shares.
No Form 144 notices for SNDL Inc. are on file.